Despite the lack of differential expression of LEFTY2 in the PBC group versus the control group in the external dataset, analysis of clinical liver samples from PBC patients revealed varying expression levels of LEFTY2 compared to normal samples. This evidence concerns the gene LEFTY2 and primary biliary cholangitis.